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Abstract
MAPPIT (mammalian protein–protein interaction trap) is a cytokine receptor-based two-hybrid method
that operates in intact mammalian cells. A bait is fused C-terminally to a STAT (signal transducer and
activator of transcription) recruitment-deﬁcient receptor, whereas the prey is linked to functional STAT-
binding sites. When bait and prey interact a ligand-dependent complementation of the STAT recruitment
deﬁciency occurs, leading to activation of a STAT-responsive reporter. MAPPIT is very well suited to study pro-
tein interactions involving activated cytokine receptors as the technique allows modiﬁcation of the bait
protein in a physiologically optimal environment.
Cytokines and their receptors
Cytokines are small messenger molecules that are involved
in cell–cell communication and are critical to many vital
processes such as embryonic development, growth, haemo-
poiesis and immune responses. They cannot cross the cellular
membrane but make use of transmembrane receptors that
capture cytokines and transmit their signal inside the cell. In
this mini-review, we will mainly focus on homomeric type I
cytokine receptors such as the EpoR (erythropoietin re-
ceptor), GHR (growth hormone receptor), LR (leptin recep-
tor) and GCSFR (granulocyte colony-stimulating factor
receptor). These cytokine receptors have no intrinsic kinase
activity but make use of associated JAKs (Janus kinases).
Upon ligand binding the JAKs are brought into close
proximity enabling them to cross-phosphorylate each other.
Subsequently the JAKs phosphorylate tyrosine residues in
the cytoplasmic receptor tail, thereby creating docking sites
for signalling molecules such as STAT (signal transducer
and activator of transcription) proteins. After binding of
these STATs they are phosphorylated in turn by the JAKs
and translocate as dimers to the nucleus where they initiate
transcription of target genes (Figure 1A). Several mechanisms
exist to modulate and terminate cytokine signalling. Among
these, the SOCS (suppressor of cytokine signalling) protein
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family plays a prominent role. These proteins are rapidly
induced upon cytokine receptor activation and are recruited
to the activated receptor complexes. They exhibit multiple
inhibitory modes including blocking of STAT binding,
inhibition of JAK activity or proteasomal targeting of the
receptor complex (for reviews, refer to [1–4]).
MAPPIT (mammalian protein–protein
interaction trap)
MAPPIT is a two-hybrid method that operates in intact
mammalian cells and is based on the JAK/STAT pathway
described above. The original MAPPIT approach as shown
in Figure 1(B) makes use of a chimaeric receptor consisting of
the extracellular domain of the human EpoR, which is a well-
characterized homodimeric receptor, and the transmembrane
and cytoplasmic tail of the long-form LR. The LR contains
only three conserved tyrosine residues in its cytoplasmic tail,
at amino acid positions 985, 1077 and 1138. To prevent the
recruitment of STAT3 and SOCSmolecules, all three tyrosine
residues were mutated to phenylalanine. A bait is then fused
C-terminally to this STAT recruitment-deficient chimaeric
cytokine receptor. The prey is linked to functional STAT
recruitment sites from the gp130 (glycoprotein 130) receptor
chain. When bait and prey interact, ligand-dependent
complementation of the STAT recruitment deficiency
occurs, leading to activation of a STAT-responsive reporter
[5].
Instead of making use of a chimaeric cytokine receptor, the
full-length LR can be used as well, with only Tyr-1138 being
mutated to phenylalanine to prevent STAT3 recruitment (Fig-
ure 1C). This way, protein interactions can be studied with
the LR in its normal oligomeric configuration [6]. In another
MAPPIT setup, we can use the wild-type EpoR (Figure 1D)
[7]. Since the EpoR signals via STAT5 and not STAT3 and
since the levels of STAT5are low in the commonlyusedHEK-
293T cells [human embryonic kidney cells expressing the
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Figure 1 JAK/STAT signalling and alternative MAPPIT setups
(A) Layout of the JAK/STAT signalling pathway. Binding of a cytokine ligand (not shown) to a CR (cytokine receptor) leads to
activation of the associated JAK tyrosine kinases. These phosphorylate tyrosine residues (Y) in the cytosolic tail of the receptor
thus providing docking sites for STAT proteins. STATs in turn are activated by the JAKs and relocalize as dimers to the nucleus
leading to stimulation of transcription of their target genes. (B) In the original MAPPIT set-up, a bait protein (B) is C-terminally
fused to a STAT recruitment-deﬁcient receptor consisting of the extracellular domain of the EpoR and the transmembrane and
intracellular portion of an LR wherein all tyrosine residues are replaced by phenylalanine (F) residues. When co-expressed
with an interacting prey (P) that is fused to a gp130 receptor fragment containing functional STAT3 recruitment sites, signalling
is restored and measured using a STAT3-responsive reporter. (C) Using the full-length LR itself as bait allows dissection of the
interaction pattern of intracellular tyrosine residues in the receptor tail. The most distal Tyr-1138 is mutated to prevent direct
signalling of the LR ‘bait’. (D) As for the LR, also the full-length EpoR can be used as a bait to analyse proteins interacting
with the receptor. (E) As only the membrane proximal region of the LR intracellular tail which is involved in binding JAK2 is
essential, the rest of the cytosolic domain can be replaced by a ﬂexible linker containing repeated GGS (Gly-Gly-Ser) units.
This allows the study of speciﬁc tyrosine motifs of the LR intracellular region. (F) In haemopoietic cells, which express no
or only very low levels of STAT3, STAT5 is used as a mediator of the MAPPIT signal. To this end, preys are coupled to a
fragment of the βc receptor containing functional STAT5 recruitment sites instead of a fragment of the gp130 receptor.
(G) In the heteromeric MAPPIT assay, the extracellular domains of the GM-CSF receptor are used to obtain a heteromeric
receptor cluster. As in the basic MAPPIT setup, the tyrosine→ phenylalanine-mutated transmembrane and intracellular
domains of the LR are used. A modifying enzyme is attached to one of the resulting receptor chains [GMRα (GM-CSF
receptor α)-LR], and the bait is fused to the other (βc-LR). This method allows the use of enzymatically modiﬁed baits.
large T-antigen of SV40 (simian virus 40)], no reporter activ-
ation can be detected after stimulation with Epo (erythropoi-
etin) allowing the use of the EpoR itself and mutants thereof
as bait. To study the isolated tyrosine motifs of the LR, we
replaced the LR cytosolic domain following the membrane-
proximal box1 motif (which is needed for the association of
the JAK kinases) by flexible Gly-Gly-Ser repeats (Figure 1E)
[6]. To be able to useMAPPIT in haemopoietic cells that have
no or very low STAT3 levels, βc (beta common) MAPPIT
was created, which employs STAT5 as a signal transducer. To
accomplice this, the prey was fused to a portion of the βc
chain containing STAT5 recruitment sites (Figure 1F) [8].
Analytical use of MAPPIT
An intrinsic feature of theMAPPIT technology is that the bait
can be tyrosine-phosphorylated by the receptor-associated
C©The Authors Journal compilation C©2008 Biochemical Society
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JAKs. This makes MAPPIT extremely useful for the study of
protein interactions involving cytokine receptors, sincemany
interactions depend onmodification by the JAKs. The differ-
ent MAPPIT set-ups (Figures 1B–1F) were used to identify
and study interactions of signalling molecules involved in
various signalling cascades initiated by homomeric type I
cytokine receptors. A brief overview is given below.
EpoR
Epo is essential for red blood cell development. Binding
of Epo to its receptor prevents apoptosis of erythroid progen-
itors and promotes proliferation and erythroid maturation.
To be able to determine the binding site of different signalling
molecules with the EpoR, we used intracellular segments
of the EpoR containing one or two tyrosine residues as
bait. Several signalling molecules served as prey including
CIS [cytokine-inducible SH2 (Src homology 2)-domain-
containing protein], SOCS2, PLCγ (phospholipase Cγ ),
STAT5a and STAT5b. Interestingly, the STAT5a and STAT5b
interaction sites were identical and overlapped with the bind-
ing sites of CIS and SOCS2, indicating that CIS and SOCS2
can inhibit STAT5 activation by blocking its recruitment site.
CIS and SOCS2 bound additional, although not completely
similar, tyrosine motifs, illustrating a differential binding be-
tween these two highly related SOCS proteins. The binding
sites of PLCγ were also identified and mutational analysis
revealed the relevant PLCγ interaction domain. The binding
sites ofCIS, SOC2 and PLCγ were confirmed using thewild-
type EpoR as bait. By mutating tyrosine residues in the
wild-type EpoR the essential docking sites were identified.
Most of theMAPPIT analyses were performed inHEK-293T
cells but subsets were confirmed in premyeloid TF-1 cells,
a more natural setting of the EpoR. Furthermore, EMSA
(electrophoretic mobility-shift assay) experiments showed
that a wild-type STAT5 prey after binding to its EpoR bait
motif could still translocate to the nucleus to bind DNA,
implying that MAPPIT can detect transient interactions
[7].
GHR
GH (growth hormone) is a pleiotropic hormone with an
important role in the regulation of postnatal growth. It
regulates carbohydrate, lipid, nitrogen and mineral metabol-
ism and can stimulate differentiation and mitogenesis of a
variety of cell types in different tissues. As for the EpoR, the
tyrosine motifs in its cytoplasmic tail were separately cloned
as bait. In striking contrast to the EpoR, the binding sites for
CIS and SOCS2 completely segregated from the STAT5a and
-b recruitment sites, ruling out SOCS-mediated inhibition
of STAT5 activation by competing for shared binding sites
[9].
LR
Leptin is critical for body weight homoeostasis by balancing
food intake and energy expenditure. It is also involved in
growth, reproduction, immune regulation, bone formation
and angiogenesis. MAPPIT analysis, both in HEK-293T
and TF-1 cells, using the mutated LR and its separate
tyrosine motifs as bait (Figures 1C and 1E), revealed that
CIS interactswithTyr-985 andTyr-1077,whereas SOCS2 and
STAT5aonly interactwithTyr-1077.Wild-type SOCS2 easily
interfereswithbindingof theCIS andSTAT5aprey at theTyr-
1077 motif, indicating that SOCS2 binds with higher affinity.
Remarkably, although SOCS2 does not bind the Tyr-985
motif, it can interfere with the binding of CIS to this site. This
unexpected finding could be explained by the direct binding
of SOCS2 on the CIS SOCS box, thereby targeting it for
proteasomal degradation [6,10]. More detailed analysis using
CIS mutants revealed that CIS binding to the LR and EpoR
not only depends on its SH2 domain but also on its SOCS
box, with a critical role for the CIS Tyr-253 and the Elongin
B/C recruitment site. Much in contrast, the SOCS box of
SOCS2 does not play a role in substrate binding [11,12].
Using the βc setup (Figure 1F), we confirmed the binding
of CIS, SOCS2 and STAT5a to the Tyr-1077 motif in the
murine Ba/F3 pro-B cell line and revealed that, in addition,
PLCγ , SOCS6 and SOCS7 also interact with the Tyr-1077
motif [8]. More recently, MAPPIT experiments in both
HEK-293T and in the physiologically highly relevant N38
hypothalamic cell line revealed that IRS4 (insulin receptor
substrate 4) interacts with the Tyr-1077 motif. Using IRS4
as bait, we confirmed the interaction with the p85 subunit of
PI3K (phosphoinositide 3-kinase), SOCS6 and SOCS7 and
documented interactions with PLCγ and SOCS2 [13].
GCSFR
The GCSFR is involved in neutrophil development by
activating pathways that control the proliferation and
survival of myeloid precursors. Using MAPPIT, we confir-
med the tyrosine-phosphorylation dependent interac-
tion of SHC (SH2-domain-containing transforming
protein), Grb2 (growth factor receptor-bound protein 2) and
Wsb-2 (WD40-repeat and SOCS box containing protein 2)
with the cytoplasmic tail of the GCSFR [14].
TLR (Toll-like receptor)
The application of MAPPIT as a tool to dissect protein inter-
actions is not limited to cytokine receptor signalling. We
recently reported the detailed MAPPIT analysis of the
signalling events downstream of TLR activation [15,16].
TLRs are activated when cells encounter pathogen-derived
structures such as lipopolysaccharide, flagellin or dsRNA
and the signalling pathways they trigger lead to a first line
of defence as part of the innate immune response. Activated
TLRs couple to downstream signalling cascades through a set
of five adaptor molecules {MyD88 (myeloid differentiation
primary response protein 88), Mal (MyD88 adaptor-like
protein), TRIF [TIR (Toll/interleukin-1 receptor)-domain-
containing adaptor inducing interferon-β], TRAM (TRIF-
related adaptor molecule) and SARM [sterile α and HEAT
(huntingtin, elongation factor 3, the PR65/A subunit of
C©The Authors Journal compilation C©2008 Biochemical Society
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protein phosphatase 2A and the lipid kinase Tor)-Armadillo
motifs containing protein]} which in part determine the
specificity of the response [17]. Combinations of TLR
intracellular domains and TLR adaptors cloned as bait and/or
prey were tested in MAPPIT, identifying novel interactions
and confirming previously documented interactions such as
the homo- and hetero-dimerization of MAL and MyD88
[15]. Interestingly, whereas the TIR domain was sufficient
for heterodimerization, the formation of homodimers of
both MyD88 and MAL also depended on other subdomains.
Intriguingly, although the role of MyD88 in TLR4 signalling
is well established, no interaction could be detected between
TLR4 and this adaptor. Co-expression of MAL however
enabled a clear MAPPIT signal, indicating that binding
between MyD88 and TLR4 is indirect and that MAL bridges
this interaction. MAPPIT was further applied in pathway
walking along one of the TLR4 signalling cascades starting
with TLR4 dimerization, and through recruitment of MAL
and MyD88 leading to association of IRAK (interleukin-1-
receptor-associated kinase)-4 and IRAK-1 [16]. TheMyD88-
independent pathway starting from TLR4 and mediated by
TRIF could not be analysed using MAPPIT as no signal was
obtained with TRIF as bait or prey. Immunofluorescence
analysis ofTRIFprey revealed that the fusionproteinwas loc-
alized to a perinuclear compartment, probably restricting it
from interacting with the membrane-proximal bait proteins.
Heteromeric MAPPIT
As shown above, MAPPIT can successfully detect modifi-
cation-independent and tyrosine phosphorylation-depen-
dent interactions. Protein modification in this approach
however strictly depends on the receptor-associated JAKs.
To allow the detection of other modification-dependent
interactions, heteromeric MAPPIT was developed. In this
variant, the homodimeric extracellular domain of the EpoR
is replaced by the extracellular parts of the heteromeric
GM-CSF (granulocyte/macrophage colony-stimulating
factor) receptor allowing fusion of a modifying enzyme
to one receptor chain and the bait to the other chain
(Figure 1G). Using this method, we were able to detect serine
phosphorylation-dependent interactions in TGF-βR (trans-
forming growth factor-β receptor) family signalling [18].
Conclusion
Using different MAPPIT set-ups (Figures 1B–1G) in
different cell lines the recruitment of various signalling and
adaptor molecules to activated receptors was studied in
greater detail. New roles for SOCS proteins and for their
prototypical SOCS box were elucidated. This shows that
the near-optimal physiological context makes MAPPIT very
well suited for the analysis of receptor signalling. Its use is
however not limited to analysing signalling cascades.We have
observed MAPPIT signals for protein–protein interactions
involved in a wide range of cellular functions including
transcriptional regulation, cell cycle control, apoptosis,
antiviral defence and so on. This warrants the use of
MAPPIT in large-scale interactome mapping programs [19].
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